Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Saad

Showing results (81-90 of 1,122) with videos related to

Pageof 113
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 18, 2013
Chemotherapy for prostate cancer: Clinical practice in CanadaFred Saad, Jamil Asselah
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practiceLaurence Klotz, Fred Saad,
Current Opinion in Supportive and Palliative Care|August 9, 2012
Preventing bone complications in prostate cancerMohamed Bishr, Fred Saad
Current Opinion in Supportive and Palliative Care|November 9, 2022
Metastatic castrate-resistant prostate cancer: a new horizon beyond the androgen receptorsSoumyajit Roy, Fred Saad
Nature Reviews. Clinical Oncology|May 14, 2014
Managing bone metastases and reducing skeletal related events in prostate cancerBenjamin A Gartrell, Fred Saad
The Canadian Journal of Urology|June 9, 2004
The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinionJ Curtis Nickel, Fred Saad
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2023
2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer Summary of changesAlan I So, Fred Saad
Current Opinion in Urology|March 13, 2010
Bone complications of androgen deprivation therapy: screening, prevention, and treatmentJean-Baptiste Lattouf, Fred Saad
Expert Review of Anticancer Therapy|August 28, 2015
The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic targetLateef A Muhammad, Fred Saad
Current Opinion in Supportive and Palliative Care|June 24, 2017
The role of bone-targeted therapies for prostate cancer in 2017Samer L Traboulsi, Fred Saad
Pageof 113

Showing results (81-90 of 1,122) with videos related to

Sort By:
Pageof 113
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|May 18, 2013
Chemotherapy for prostate cancer: Clinical practice in CanadaFred Saad, Jamil Asselah
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|June 11, 2008
PCPT, MTOPS and the use of 5ARIs: a Canadian consensus regarding implications for clinical practiceLaurence Klotz, Fred Saad,
Current Opinion in Supportive and Palliative Care|August 9, 2012
Preventing bone complications in prostate cancerMohamed Bishr, Fred Saad
Current Opinion in Supportive and Palliative Care|November 9, 2022
Metastatic castrate-resistant prostate cancer: a new horizon beyond the androgen receptorsSoumyajit Roy, Fred Saad
Nature Reviews. Clinical Oncology|May 14, 2014
Managing bone metastases and reducing skeletal related events in prostate cancerBenjamin A Gartrell, Fred Saad
The Canadian Journal of Urology|June 9, 2004
The American Urological Association 2003 guideline on management of benign prostatic hyperplasia: a Canadian opinionJ Curtis Nickel, Fred Saad
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 19, 2023
2022 UPDATE: Canadian Urological Association-Canadian Urologic Oncology Group guideline: Metastatic castration-naive and castration-sensitive prostate cancer Summary of changesAlan I So, Fred Saad
Current Opinion in Urology|March 13, 2010
Bone complications of androgen deprivation therapy: screening, prevention, and treatmentJean-Baptiste Lattouf, Fred Saad
Expert Review of Anticancer Therapy|August 28, 2015
The role of clusterin in prostate cancer: treatment resistance and potential as a therapeutic targetLateef A Muhammad, Fred Saad
Current Opinion in Supportive and Palliative Care|June 24, 2017
The role of bone-targeted therapies for prostate cancer in 2017Samer L Traboulsi, Fred Saad
Pageof 113